You're Training Hard and Still Losing Muscle. Here's the Biological Reason.

FTO encodes a protein that regulates hunger and satiety signaling in your brain. It modulates the appetite centers in your hypothalamus, controlling whether you feel satisfied after eating and how much you crave high-calorie, high-fat foods. When FTO is working normally, you eat, you feel full, and you stop.

The rs9939609 A allele, present in roughly 45% of people with European ancestry, disrupts this satiety signal. People carrying the A allele experience blunted fullness cues and increased preference for high-fat, energy-dense foods. This variant doesn’t make you weak-willed. It literally changes how your brain interprets the signal that you’re full.

For sarcopenia prevention, this matters enormously. Building muscle requires a caloric surplus or at least caloric balance plus resistance training. If your satiety signals are impaired, you unconsciously overconsume, your body stores excess energy as fat instead of building muscle, and your body composition drifts toward sarcopenia (low muscle, higher fat percentage). You can eat ‘clean’ and still gain the wrong tissue type.

PPARG encodes a receptor that controls how your fat cells behave, specifically whether they store energy efficiently or release it. The Pro12Ala variant affects this function. The Pro12 allele, which roughly 75% of people carry, promotes efficient fat cell uptake and storage. This was evolutionary advantage in times of scarcity. In modern nutrition, it means your body preferentially stores excess energy as fat.

The mechanism is straightforward: Pro12 allele carriers have fat cells that are very efficient at accepting and storing triglycerides, especially from high-carbohydrate or high-fat meals. This means even when you’re eating in a mild surplus to gain muscle, your body tends to store the surplus as fat rather than directing it toward muscle protein synthesis.

For sarcopenia prevention, this creates a specific problem: you cannot easily achieve a body composition that favors muscle gain over fat gain. You can follow a ‘clean bulk’ and still end up with a higher fat percentage. Your body is biologically tuned to store, not to mobilize. This makes resistance training less effective because the stimulus isn’t being met with the nutrient partitioning that builds muscle.

ADRB2 encodes the beta-2 adrenergic receptor, which sits on your fat cells and responds to the stress hormone norepinephrine (released during exercise, cold exposure, or stress). When this receptor functions normally, exercise triggers norepinephrine release, which binds to ADRB2, and your fat cells release stored triglycerides into the bloodstream for energy. This is fat mobilization, essential for both body composition and muscle preservation during caloric balance or slight deficit.

Two common variants, Gln27Glu and Arg16Gly, impair this response. Roughly 40% of people carry one or both variants, which reduce the sensitivity of fat cells to norepinephrine signaling. Your fat cells simply don’t respond as robustly when exercise signals them to release energy. You can do the same workout as someone with a normal receptor, burn fewer fat calories, and have less energy available for muscle work.

For sarcopenia prevention, this is particularly damaging. During resistance training, you need energy mobilized from fat stores to fuel intense muscle contractions. If your fat cells aren’t responding to the signal, you’re left in an energy deficit that your body meets by breaking down muscle protein for fuel. You’re training hard, but your fat isn’t mobilizing to support the effort, so your muscles get catabolized instead.

ACTN3 encodes alpha-actinin-3, a protein in the Z-disc of muscle fibers that is critical for fast-twitch (explosive, powerful) muscle fiber function. The R577X variant is a stop codon: the X allele produces non-functional protein in fast-twitch fibers. Roughly 18% of people with European ancestry are X/X, meaning they lack functional ACTN3 in fast-twitch fibers entirely.

This creates a clear shift in muscle fiber composition: X/X individuals have a reduced fast-twitch fiber population and cannot generate the same explosive power as R-allele carriers. This doesn’t mean weak muscles; it means your fast-twitch fibers are structurally limited in their ability to produce force rapidly. Your endurance and aerobic capacity may actually be better, but your power output is constrained.

For sarcopenia prevention, this matters because resistance training and the explosive movements that recruit fast-twitch fibers are the most powerful anti-aging stimuli for muscle retention. If your genetics limit fast-twitch fiber function, the primary training stimulus for building the muscle fibers most vulnerable to aging is reduced. You have to train smarter: longer time under tension, eccentric emphasis, and moderate-to-heavy loads that maximize recruitment of your available fast-twitch fibers.

LEPR encodes the leptin receptor, which sits in your brain and receives signals from leptin, the satiety hormone released by fat cells. Leptin’s job is simple: tell your brain that you’ve eaten enough and to stop eating. Variants in LEPR impair this signaling. Roughly 20-30% of the population carry functional variants that reduce leptin receptor sensitivity.

When your leptin receptor isn’t working optimally, your brain doesn’t receive adequate satiety signals even when leptin levels are normal. You can be well-fed and metabolically replete, but your brain receives a signal of deprivation. This drives increased hunger, reduced satiety after meals, and a tendency to overeat, especially high-calorie foods. It’s not about willpower; your brain literally doesn’t register the stop-eating signal.

For sarcopenia prevention, this is compounded by FTO and PPARG effects. Your appetite signaling is dysregulated from multiple directions: your satiety circuits aren’t receiving leptin signals optimally, your general hunger/fullness sensing is impaired, and your body preferentially stores excess calories as fat. The result is progressive fat gain with loss of muscle percentage over time. You’re eating more than you realize, storing it as fat, and your muscles are disappearing inside an expanding body.

VDR encodes the vitamin D receptor, through which activated vitamin D (calcitriol) triggers muscle protein synthesis, calcium signaling in muscle cells, and immune regulation necessary for recovery. The BsmI and FokI variants are common. Roughly 30-50% of people carry variants that impair VDR function, reducing the efficiency of vitamin D signaling in muscle tissue even when serum vitamin D levels are ‘normal’.

The mechanism is direct: VDR variants reduce the muscle cell’s ability to respond to vitamin D signals, impairing both calcium handling (essential for contraction and recovery) and the gene expression changes required for muscle protein synthesis after training. You can take vitamin D supplements and have a serum level of 40-50 ng/mL and still have impaired muscle recovery and adaptation because your muscle cells aren’t responding optimally to the signal.

For sarcopenia prevention, this is catastrophic. Muscle protein synthesis after resistance training is already declining with age. If your genetic variants add another layer of impairment, your training stimulus yields less muscle growth. Your recovery is slower. Your muscles cannot adapt as robustly to training stress. This accelerates the progression of sarcopenia.